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ABSTRACT
Objective To determine whether the instantaneous
wave-free ratio (iFR) can detect improvement in stenosis
signiﬁcance after percutaneous coronary intervention
(PCI) and compare this with fractional ﬂow reserve (FFR)
and whole cycle Pd/Pa.
Design A prospective observational study was
undertaken in elective patients scheduled for PCI with
FFR ≤0.80. Intracoronary pressures were measured at
rest and during adenosine-mediated vasodilatation,
before and after PCI. iFR, Pd/Pa and FFR values were
calculated using the validated fully automated
algorithms.
Setting Coronary catheter laboratories in two UK
centres and one in the USA.
Patients 120 coronary stenoses in 112 patients were
assessed. The mean age was 63±10 years, while 84%
were male; 39% smokers; 33% with diabetes. Mean
diameter stenosis was 68±16% by quantitative coronary
angiography.
Results Pre-PCI, mean FFR was 0.66±0.14, mean iFR
was 0.75±0.21 and mean Pd/Pa 0.83±0.16. PCI
increased all indices signiﬁcantly (FFR 0.89±0.07,
p<0.001; iFR 0.94±0.05, p<0.001; Pd/Pa 0.96±0.04,
p<0.001). The change in iFR after intervention (0.20
±0.21) was similar to ΔFFR 0.22±0.15 (p=0.25). ΔFFR
and ΔiFR were signiﬁcantly larger than resting ΔPd/Pa
(0.13±0.16, both p<0.001). Similar incremental changes
occurred in patients with a higher prevalence of risk
factors for microcirculatory disease such as diabetes and
hypertension.
Conclusions iFR and FFR detect the changes in
coronary haemodynamics elicited by PCI. FFR and iFR
have a signiﬁcantly larger dynamic range than resting
Pd/Pa. iFR might be used to objectively document
improvement in coronary haemodynamics following PCI
in a similar manner to FFR.
INTRODUCTION
The instantaneous wave-free ratio (iFR) is an inva-
sive, pressure-only index of coronary stenosis severity
measured without pharmacological vasodilatation. It
is calculated over ﬁve heart beats as the ratio of distal
to proximal coronary pressures during the diastolic
wave-free period of the cardiac cycle, when distal
intracoronary resistance is stable and minimal.1 In
ADVISE and ADVISE-Registry studies, and in an
independent blinded cohort (the South Korean pro-
spective study), the stenosis severity classiﬁcation of
iFR matched fractional ﬂow reserve (FFR) in over
80% cases1–3; this was higher when accounting for
the test-retest variability of FFR around its thresh-
old.2 CLARIFY further demonstrated high diagnostic
agreement with hyperaemic stenosis resistance a ﬂow-
based index of ischaemia.4
However, it is unknown whether iFR can detect
changes in coronary haemodynamics immediately
following percutaneous coronary intervention
(PCI). If detectable, they may be useful to document
improvements in haemodynamics following PCI.
In this study, we explored whether (1) iFR
changed in patients undergoing PCI and (2)
whether the size of the increment was similar in
proportion to measurements obtained under
adenosine-mediated hyperaemic conditions.
METHODS
Study population
Patients with angina undergoing elective coronary
angioplasty for clinical reasons were prospectively
enrolled for pressure wire assessment before and
after intervention. FFR was used as the reference
standard to detect signiﬁcant epicardial stenoses
and only patients with physiologically signiﬁcant
lesions (FFR values ≤0.80) were included.
Diabetes was deﬁned as the use of oral hypogly-
caemic agents or subcutaneous insulin injection.
Hypertension was deﬁned by a formal diagnosis by
the referring physician. Hypercholesterolaemia was
deﬁned as requiring a statin with total cholesterol
≥5 mmol/L and low density lipoprotein
(LDL)≥2 mmol/L. Smoking status was patient
reported and dichotomised as currently smoking
cigarettes (including recent discontinuation within
1 year) and those who are never smokers or
stopped over 1 year ago.
Patients were recruited from the Imperial College
Healthcare NHS Trust, the Veterans Affairs
Medical Center, Little Rock, Arkansas, USA and
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the John Radcliffe Hospital, Oxford, UK. The protocol was
approved by local institutional review boards and ethics com-
mittees and patients provided written informed consent (NRES
09/H0712/102; NCT01118481).
Study protocol: coronary catheterisation
Coronary angiography and pressure wire assessments of coron-
ary stenoses were performed using conventional approaches.
Intracoronary nitrates were administered in all cases before pres-
sure wires were introduced. Pressure wires were normalised at
the coronary ostia before every pressure recording. If more than
one stent was used within one coronary segment, the pressure
analysis was performed for the complete segment. For post-
angioplasty measurements, all stents were optimised with postdi-
lation where angiographically indicated before further
assessment with the pressure wire. Repeated measurements were
performed after the angioplasty balloon had been removed, the
catheter ﬂushed and nitrates administered again. The pressure
wire was normalised at the vessel ostium and then measure-
ments were made at the same coronary location as pre-
angioplasty.
All patients received an oral loading dose of aspirin 300 mg
and clopidogrel 600 mg, and intravenous heparin according to
weight, together with bivalirudin or GPIIbIIIa-antagonist accord-
ing to clinical indication.
Haemodynamic recordings
Pressure wire recordings were made using the Pressure Wire
Aeris (St. Jude Medical, Minneapolis, Minnesota) and Prestige
pressure guide wire (Volcano Corporation, San Diego,
California). Digital haemodynamic data were extracted from
data storage systems (Radiview, St Jude Medical and
ComboMap, Volcano Corporation) and processed off-line in a
core laboratory using a custom software package with Matlab
(Mathworks, Inc., Natick, Massachusetts).
Calculation of Pd/Pa, iFR and FFR
iFR was calculated as a ratio of the distal coronary pressure to
proximal coronary pressure at rest, using the validated auto-
mated algorithms with phase alignment acting over the diastolic
wave-free period over a minimum of ﬁve beats. iFR is measured
using pressure-only, at baseline, without adenosine administra-
tion1(ﬁgure 1).
Pd/Pa ratio was calculated using the ratio of distal coronary
pressure to proximal coronary pressure at rest over the entire
cardiac cycle.
FFR measurements were performed using a standard tech-
nique,5 using the ratio of distal coronary pressure to proximal
pressure during conditions of stable hyperaemia. Hyperaemia
was induced by adenosine infusion at a rate of 140 mcg/kg/min,
administered by femoral venous access in 96 (80%) stenoses and
an intracoronary 60 mcg bolus in 24 (20%) stenoses.
Figure 1 Calculation of iFR over the resting wave-free window. Using an automated off-line algorithm, iFR was calculated at rest from the
distal-to-proximal pressure ratio during the wave-free period.
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Data analysis
Statistical analysis was performed using Matlab (Mathworks Inc,
Massachusetts, USA) and STATAV.11 (StataCorp, Texas). Values
are expressed as mean±SD. Continuous variables were com-
pared using the Student t test or Mann-Whitney U test.
Subgroup data was assessed using ANOVA with repeated mea-
sures and the Bonferroni correction for multiple testing errors.
The relationship between the change in pressure wire indices
and stenosis severity based upon quantitative coronary angiog-
raphy (QCA) were quantiﬁed using Pearson’s product moment
correlation coefﬁcient. This study had 90% power to detect a
difference of a 0.03 or greater difference between the delta in
iFR and FFR after PCI. A p value <0.05 was considered statis-
tically signiﬁcant.
RESULTS
Patient characteristics
A hundred and twelve patients (63±10 years old, 84% male)
with 120 coronary stenoses were included. Patient demographics
are shown in table 1. QCA demonstrated a mean diameter sten-
osis of 68±16%, and lesion length of 15.6±9.2 mm.
Haemodynamic parameters
The mean haemodynamic parameters at rest and during adenosine
infusion, before and after PCI are shown in table 2. Adenosine sig-
niﬁcantly increased heart rate and reduced systolic, diastolic and
mean blood pressures compared with resting values and this
occurred before and after angioplasty. The delta (Δ) in each param-
eter at rest, before and after PCI, was not signiﬁcantly different
from the hyperaemic delta before and after PCI (p>0.12).
Responses did not differ within subgroups conventionally asso-
ciated with higher levels of microcirculatory disease including
people with diabetes, hypertension or current smokers (table 2).
Preangioplasty stenosis evaluation
Mean FFR was 0.66±0.14 (median 0.72, 0.56–0.78); mean Pd/
Pa was 0.83±0.16 (median 0.90, 0.81–0.93); mean iFR was
0.75±0.21 (median 0.84, 0.65–0.89). The overall mean FFR
was similar to the FAME and FAME-II studies.6 7 Eighty-four
stenoses (70%) were within FFR 0.6–0.80 range (with mean
FFR 0.75±0.05, mean iFR 0.85±0.08, mean Pd/Pa 0.91±0.04)
while 71 stenoses (59%) were within FFR 0.70–0.80 range
(mean FFR 0.76±0.03, mean iFR 0.86±0.07, mean Pd/Pa 0.91
±0.04). Using the iFR 0.90 cut-off to correspond to the FFR
0.80 cut-off, 86% classiﬁcation match was found in this cohort.
Intracoronary adenosine was used in 24 stenoses: there was
no signiﬁcant difference in the FFR values measured using intra-
coronary adenosine versus intravenous adenosine infusion,
either before (p=0.83) and or after PCI (p=0.79).
Resting indices can be lower than hyperaemic indices
In 26 stenoses (22%) the pre-PCI iFR value was numerically
lower than FFR (iFR 0.45±0.20, FFR 0.55±0.16). This is a
similar proportion to that reported in other studies.1 2 4 8 9
These lesions were anatomically more severe (diameter stenosis:
75±14% vs 66±16%, p=0.01) and were physiologically more
signiﬁcant (FFR 0.55±0.16 vs 0.69±0.12, p<0.01) than the
remainder of the study population. There was no signiﬁcant dif-
ference in heart rate or systolic and diastolic pressures between
these individuals and the others (p≥0.10). There was also no
signiﬁcant difference in the rates of diabetes mellitus, hyperten-
sion or smoking status (p≥0.26); although hyperlipidaemia was
more common in the group where FFR was lower than iFR
(75% vs 87%, p=0.03). In contrast, Pd/Pa was numerically
lower than FFR in only three stenoses (2.5%; values 0.70, 0.20,
0.50) and in all three cases iFR was lower (0.47, 0.13, 0.28,
respectively) than Pd/Pa and FFR (0.73, 0.23, 0.56 respectively).
iFR was lower than Pd/Pa in all stenoses, by a mean of 0.08
±0.07 units, p<0.001. Figure 2 shows the gain offered by iFR
over Pd/Pa across the entire study.
Postangioplasty stenosis evaluation
Coronary intervention was angiographically successful in all
cases and physiological measures were only performed once
angiographic or intracoronary imaging based optimisation had
been performed. Mean residual stenosis after stenting, measured
by QCA, was 14.1±8.2%. The mean of all three indices
increased signiﬁcantly after angioplasty (iFR 0.75±0.21 to 0.94
±0.05, p<0.001; Pd/Pa 0.83±0.16 to 0.96±0.04, p<0.001;
and FFR 0.66±0.14 to 0.89±0.07, p<0.001).
Table 1 Patient demographic data
Number (%)
Patients 112
Age, yrs 63±10
Male 94 (84)
Diabetes 37 (33)
Smoker 44 (39)
Hypertension 90 (80)
Hyperlipidaemia 92 (82)
Renal failure on dialysis 3 (3)
Previous myocardial infarction 18 (16)
Impaired LV function EF<30% 13 (12)
Previous CABG 14 (13)
Stable angina 91 (81)
Unstable angina 21 (19)
Single-vessel disease 51 (46)
Multivessel disease 61 (54)
Stenoses 120
Coronary vessel
Left main stem 2 (2)
Left anterior descending 63 (53)
Diagonal 4 (3)
Intermediate 2 (2)
Circumflex 15 (13)
Obtuse marginal 6 (5)
Right coronary 21 (18)
Posterior descending 1 (1)
Saphenous vein graft 6 (5)
Lesion location in vessel
Proximal 62 (52)
Mid 52 (43)
Distal 6 (5)
Lesion characteristics
Lesion severity (QCA %) 68±16
Lesion length (QCA mm) 15.6±9.2
Adenosine administration
Central intravenous 96 (80)
Intracoronary bolus 24 (20)
Values are n, mean±SD or n (%). Risk factors are defined in the text.
CABG, coronary artery bypass grafting; EF, ejection fraction; LV, left ventricular;
QCA, quantitative coronary angiography.
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Change in iFR, Pd/Pa and FFR after intervention
Across the whole study population, the change after interven-
tion was signiﬁcantly higher for iFR than Pd/Pa (ΔiFR 0.20
±0.21 vs ΔPd/Pa 0.13±0.16, p=0.007) and was statistically
similar for iFR and FFR (ΔiFR 0.20±0.21 vs ΔFFR 0.22±0.15,
p=0.25, ﬁgure 3A). The magnitude of change elicited by PCI,
that is the delta as a percentage of the pre-PCI value, was not
signiﬁcantly different between iFR (48±92%) and FFR
(42±47%; p=0.34). The magnitude of change for Pd/Pa
(23±45%) was signiﬁcantly smaller than iFR (p<0.001) and
FFR (p<0.001) (ﬁgure 3B).
The ﬁndings were unchanged when iFR and FFR agreed
(iFR≤0.90, FFR≤0.80) in 103 stenoses, ΔiFR 0.22±0.21 vs
ΔFFR 0.24±0.15, was not signiﬁcantly different (p=0.57);
both were signiﬁcantly greater than seen with ΔPd/Pa (0.15
±0.16, p<0.01 for both). In the 17 stenoses with iFR>0.90
pre-PCI, the ΔFFR was much smaller than when iFR≤0.90
(0.12±0.06 vs 0.24±0.15, p=0.002). Similarly, the ΔiFR was
smaller (0.03±0.03 vs 0.22±0.21, p<0.001) but remained
larger than seen with ΔPd/Pa (0.02±0.03, p<0.001).
After PCI, six stenoses had iFR values lower than FFR (with a
difference of 0.05±0.04 in the value between the two indices).
There was no difference in the QCA of these stenoses and the rest
of the study population (9.8±2.1% vs 14.8±8.5%, p=0.24). In
the subset of 26 stenoses in which pre-PCI iFR was lower than
FFR, the change in iFR post-PCI was signiﬁcantly greater than the
change in FFR and Pd/Pa in the same lesions: ΔiFR 0.47±0.23
(magnitude 158±148%) versus ΔFFR 0.32±0.18 (magnitude
74±64%), p=0.01; versus ΔPd/Pa 0.33±0.18 (magnitude 70
±76%), p=0.02.
Stenoses remaining ischaemic or worsening after
intervention
The majority of lesions showed haemodynamic improvement
after PCI. However, in a small number of cases the post-PCI
values were lower. This was found in all indices in similar pro-
portions (iFR:4%, FFR:2% and PdPa:7%, p>0.25 for all)
(ﬁgure 4), with overall very small falls in index values (iFR:0.05
±0.05, FFR:0.04±0.02, PdPa:0.02±0.02). Overall 15 stenoses
had a FFR≤0.80 post-PCI (FFR 0.76±0.04) and 12 cases with
iFR (iFR≤0.90; mean iFR 0.85±0.06).
Lesion severity and impact upon physiological improvement
Pre-PCI lesion severity as determined by anatomical stenosis inﬂu-
enced the magnitude of physiological improvement (ﬁgure 5).
Preangiographic QCA was related to the delta in physiological
index (ΔFFR r=0.57, ΔiFR r=0.49, ΔPd/Pa r=0.51). Regression
analysis demonstrated strongly signiﬁcant positive relationship of
initial lesion severity by QCA (percentage change in FFR R2 0.26,
iFR R2 0.16, Pd/Pa R2 0.16, each p<0.0001).
Table 2 Haemodynamic changes observed at rest and during adenosine-mediated hyperaemia, before and after coronary angioplasty
Preangioplasty Postangioplasty Delta
Haemodynamic parameter Resting Adenosine
Rest versus
adenosine p value Resting Adenosine
Rest versus
adenosine p value
Resting
pre–post
Adenosine
pre-post
Rest versus
adenosine p value
All stenoses
Heart rate 68±12 73±12 <0.001 68±13 73±14 <0.001 0±7 1±7 0.21
Mean systolic pressure 119±27 104±26 <0.001 124±27 105±28 <0.001 5±25 1±24 0.12
Mean diastolic pressure 66±14 56±14 <0.001 69±13 58±14 <0.001 3±12 0±13 0.15
Mean arterial pressure 80±16 68±16 <0.001 84±16 69±18 <0.001 3±15 1±16 0.14
Diabetes
Heart rate 70±12 72±12 0.01 69±13 73±12 0.003 0±4 1±5 0.56
Systolic blood pressure 121±26 111±14 0.002 122±31 106±32 <0.001 2±23 −4±19 0.17
Diastolic blood pressure 65±14 59±13 0.001 66±14 56±16 <0.001 1±10 −3±11 0.14
Mean arterial pressure 80±17 71±14 <0.001 81±17 68±20 <0.001 1±13 −3±14 0.15
Hypertension
Heart rate 66±13 68±12 0.03 66±13 70±13 <0.001 0±4 2±6 0.41
Systolic blood pressure 109±25 101±25 0.01 113±26 101±23 <0.001 5±22 0±25 0.2
Diastolic blood pressure 61±13 56±13 0.01 64±14 56±12 <0.001 3±11 0±14 0.23
Mean arterial pressure 74±16 67±15 0.002 78±16 67±15 <0.001 3±13 1±17 0.23
Smoking
Heart rate 70±13 76±13 <0.001 70±14 75±15 <0.001 0±9 −1±9 0.98
Systolic blood pressure 127±27 110±26 <0.001 128±31 111±32 <0.001 2±28 −2±25 0.33
Diastolic blood pressure 68±14 58±14 <0.001 70±14 59±14 <0.001 1±14 −2±13 0.33
Mean arterial pressure 84±17 72±15 <0.001 86±18 72±18 <0.001 2±16 −2±16 0.27
Figure 2 The difference in preintervention iFR and Pd/Pa values. The
difference between iFR and Pd/Pa is shown against preintervention Pd/
Pa values. iFR was lower than Pd/Pa by a mean of 0.08±0.07 across all
stenoses.
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Figure 3 The mean change in preangioplasty and postangioplasty Pd/
Pa, iFR and FFR values. Fractional ﬂow reserve (FFR) and instantaneous
wave-free ratio (iFR) and whole cycle Pd/Pa values before and after
coronary angioplasty. Mean and standard error pre-PCI and post-PCI
values are shown as vertical lines. Red horizontal lines represent
stenoses which have a fall in index after PCI.
Figure 4 The change in preangioplasty and postangioplasty FFR and iFR values for individual stenoses. Fractional ﬂow reserve (FFR) and
instantaneous wave-free ratio (iFR) and whole cycle Pd/Pa values before and after coronary angioplasty. The red line shows the average pre and post
values, while the error bars show SD.
Figure 5 Improvement in iFR, Pd/Pa or FFR is closely associated with
the angiographic severity of the stenosis. The change in index is shown
as a percentage of the preangioplasty result (A) according to the lesion
severity measured by percentage diameter stenosis and (B) by
preintervention FFR value. A larger pre–post-PCI difference in iFR was
observed in more severe lesions when compared with less severe
lesions.
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Post-PCI, residual stenosis severity measured by QCA had no
strong relationship with either physiological measure (iFR
r=0.24; FFR r=0.12). There was a modest relationship
between the degree of improvement in angiographic severity
(ΔQCA) and change in iFR (r=0.34) and change in FFR
(r=0.40).
Impact of diabetes, smoking status and hypertension on
magnitude of increase of iFR and FFR post-PCI
No signiﬁcant difference was observed when patients with
hypertension, diabetes or smokers were compared with patients
without these conditions (table 3). The change in iFR was sig-
niﬁcantly larger than Pd/Pa after PCI in patients with hyperten-
sion, those without diabetes and non-smokers.
Haemodynamic changes induced by PCI
The change in heart rate, measured during resting or hyper-
aemic conditions, after PCI had no relationship to the change in
iFR (R2 0.004) nor FFR (R2 0.007). Similarly, change in mean
arterial pressure after PCI had no relationship with change in
iFR (R2 0.004) nor FFR (R2 0.002).
DISCUSSION
In this study, we found that in stenoses that typically undergo
intervention (1) resting indices of stenosis severity can detect a
change after PCI, with iFR and Pd/Pa values improving after
successful PCI; (2) the change in iFR and FFR is similar; (3) the
change seen is larger with FFR and iFR than seen with Pd/Pa.
Gruntzig’s demonstration that resting trans-stenotic pressure
gradients could detect change after angioplasty was limited by
bulky low-ﬁdelity pressure-sensing equipment.10 Hyperaemia
improved sensitivity for whole-cycle averaged measures by
increasing ﬂow in stenoses which by deﬁnition must be
non-ﬂow limiting.4 iFR provides an alternative approach to
increasing sensitivity, by automatically identifying a phase in dia-
stole —the wave-free period—when trans-stenotic ﬂow is highest
during the resting cardiac cycle. Our ﬁndings conﬁrm that using
either of these approaches it is possible to observe a similar
improvement in trans-stenotic pressure gradients after PCI.
The challenges for pressure-only indices after PCI
Changes in trans-stenotic pressure gradients after coronary inter-
vention, to remove an obstruction to ﬂow, are a measure of the
effect of the procedure.10–12 However, it is possible despite suc-
cessful anatomical resolution of a coronary stenosis, unwanted
or unaccounted for effects of PCI itself may pose difﬁculties for
post-PCI physiological evaluation. Such effects included altered
haemodynamics,13 changes in microcirculatory resistance,14 and
altered responsiveness to adenosine due to microembolisation.15
The impact may vary according to initial lesion severity,16 17 the
stenting strategy18 and even concomitant drugs.19 Nonetheless,
FFR has been shown to be of use to measure the incremental
improvement in trans-stenotic gradient after balloon angioplasty,
stent deployment, and following poststent high pressure balloon
inﬂation and many of the theoretical concerns of a blunted
microcirculatory response to adenosine after PCI have proved
unfounded.20–24 The information has clinical utility also, with
post-PCI FFR predicting restenosis and major adverse cardiovas-
cular events.20–22 25–28 While intravascular ultrasound (IVUS)
and/or optical coherence tomography should remain the stand-
ard to assess quality of stent deployment and apposition,
post-PCI physiology does reﬂect the end lumen area29 30 and
provides an assessment of the effects of the residual coronary
disease to likely vessel ischaemia.
Resting markers of lesion severity can detect lesion
signiﬁcance before PCI
Resting parameters are known to correlate with hyperaemic
measures31 and experts agree that hyperaemia is not required
for stenoses with signiﬁcant resting gradients.32 By using only
the diastolic wave-free period, iFR offers the lowest resistance
over the cardiac cycle1 33 and incremental beneﬁt in the number
of stenoses that can be safely assessed without adenosine.34
However, it was unclear whether resting measures would have
sufﬁcient dynamic range to detect improvement after PCI.
In this study, iFR as a resting index could distinguish
improvement in stenosis severity similarly as FFR in a wide
range of stenoses that would be selected for PCI. Pd/Pa also
detected improvement albeit with a signiﬁcantly smaller
Table 3 Patients with risk factors for microcirculatory disease have a similar change in iFR and FFR produced by PCI
Delta pre–post-PCI
Risk for microvascular disease No of stenoses FFR iFR Pd/Pa iFR versus FFR iFR versus Pd/Pa
Hypertension
No hypertension 25 0.19±0.14 0.16±0.19 0.11±0.13 0.12 <0.001
Hypertension 95 0.23±0.15 0.20±0.21 0.13±0.16 0.06 <0.001
p Value 0.31 0.35 0.22
Diabetes
No diabetes 80 0.22±0.14 0.18±0.20 0.12±0.15 0.01 <0.001
Diabetes 40 0.23±0.17 0.23±0.23 0.15±0.18 0.71 <0.001
p Value 0.56 0.25 0.27
Smoking status
Non-smoker 72 0.16±0.19 0.18±0.19 0.12±0.15 0.11 <0.001
Smoker 48 0.26±0.15 0.22±0.22 0.15±0.16 0.09 <0.001
p Value 0.07 0.27 0.24
Multiple risks
No risk factors 9 0.14±0.13 0.13±0.17 0.09±0.12 0.85 0.04
Diabetic, hypertensive, smoker 13 0.22±0.14 0.22±−0.22 0.14±0.16 0.95 0.004
0.22 0.37 0.38
Delta in indices was compared according to the presence of hypertension, diabetes and smoking status. ANOVA was performed with post hoc testing and Bonferroni correction.
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increment when compared with either FFR or iFR. All three
measures, despite representing quite different physiological
parameters, have a close correlation and therefore have clinical
utility. However, as the onus falls upon the interventionist for
demonstrating physiological functional gain after PCI, having a
greater dynamic range, as offered by iFR and FFR, may be
considered preferable. This is particularly pertinent to deter-
mine the signiﬁcance of residual disease. The larger dynamic
range offered by iFR and FFR over Pd/Pa means they have a
greater range to diagnose stenoses and detect potentially small
incremental improvements. If the potential dynamic range of
improvement is small, important but smaller residual gradients
may not be detected using a whole cycle Pd/Pa approach.
Theoretically, this greater dynamic range may also be helpful in
serial stenoses where greater discrimination is required to
understand the impact of each stenosis and the effects of PCI
to a given stenosis.
With FFR and iFR offering an equivalent magnitude of
change on average for stenoses selected for intervention, proce-
dures could be performed without vasodilators while being able
to assess the change in an equivalent manner as when vasodila-
tors are used. However, we did not seek to ﬁnd an optimal
‘cut-off ’ for post-PCI iFR that predicts outcome or vessel size.
Further work with long-term follow-up and intravascular
imaging is warranted.
In this study FFR<0.80 was used as the entry criteria. As a
result, in some cases iFR and Pd/Pa were negative, while by
study design FFR was always positive. In these cases, the rise in
iFR and Pd/Pa was signiﬁcantly smaller after PCI, than seen
when iFR agreed with FFR. The implications as yet are unclear.
Currently there is a signiﬁcant body of evidence to support the
FFR clinical cut-off value of 0.80. Further clinical studies are
needed evaluate the clinical signiﬁcance of these differences,
and to assess the likely implications for clinical outcomes.
Practical assessment of iFR after PCI
It is frequently thought that signiﬁcant haemodynamic shifts
caused by PCI may affect the ability of basal parameters to
detect change after PCI. However, in this study, haemodynamic
parameters at rest changed in a similar manner to those para-
meters measured during hyperaemia. Under resting and hyper-
aemic conditions, the absolute change after PCI was small and
there was no relationship between the change in heart rate or
blood pressure with the change in iFR or FFR post-PCI. This is
similar to the relative heart rate and blood pressure independ-
ence reported in CLARIFY and by Johnson et al4 9
Immediately after balloon deﬂation, dynamic changes asso-
ciated with occlusive reactive hyperaemia may produce artiﬁ-
cially lower iFR values. This is similar to injecting intracoronary
nitrates or contrast.11 When this occurs it may lead to lower
values of iFR. Reactive hyperaemia following transient balloon
occlusion is similar to hyperaemia from intracoronary adeno-
sine, typically lasting a short duration (5–30s) with a rapid
return to basal conditions.35–38 Our ﬁnding show that provided
post-PCI iFR measurements are made in a manner similar to
FFR, that is after the deﬂated balloon is withdrawn and the
guiding catheter is ﬂushed, the hyperaemic effect is extremely
short-lived and is of little clinical consequence as iFR and FFR
have similar numbers of cases in which the post-PCI value is
lower than the pre-PCI value.
iFR values can be lower than FFR values in severe lesions
In this study sample of stenoses suitable for PCI, one in ﬁve
(22%) stenoses had a pre-PCI iFR lower than FFR: that is the
resting translesional pressure ratio was lower at rest than that
achieved during stable maximal hyperaemia. While apparently
counterintuitive, this phenomenon is well recognised in
pressure-ﬂow based studies, and occurs in all iFR-FFR compara-
tor studies.1 2 4 8 9 The chance of an iFR measurement being
lower than a FFR measurement increases with increasing disease
severity. However, even in intermediate populations this occurs
with a frequency of 8–15%. With increasing stenosis severity,
where each patient undergoing PCI had a FFR <=0.80, the
proportion of patients with a lower iFR than FFR increases
signiﬁcantly.
However counterintuitive a lower resting than hyperaemic
measurement may appear, the physiological principles underlying
the phenomenon are well described.17 39 40 Coronary ﬂow is
maintained during resting conditions even in the presence of a
coronary stenosis up to 90% because the microcirculation natur-
ally vasodilates, reducing resistance, to preserve basal ﬂow.39–41
In such severe stenoses, trans-stenotic ﬂow is strongly inﬂuenced
by proximal driving pressure which itself is maintained by autore-
gulation. In this setting, adenosine offers no additional vasodila-
tion than naturally present, and resistance does not fall by as
much as seen in non-ﬂow limiting vessels.4 17 However, the fall
in central blood pressure particularly with intravenous adenosine
can be sufﬁcient to reduce the driving pressure across the stenosis
with reduction in distal distending pressure. A loss in perfusion
pressure leads to protective microcirculatory vasoconstriction,
much like that seen in the peripheries during shock. This para-
doxical vasoconstriction of the microvasculature leads to a rise in
distal resistance17 42 and may be sufﬁcient to attenuate trans-
stenotic gradients during stable hyperaemia. A typical case from
the ADVISE study is demonstrated in ﬁgure 6 in which the
resting iFR was 0.56 and the FFR 0.81.
Figure 6 Resting gradients can be lower than hyperaemic gradients.
The resting iFR is 0.57 and Pd/Pa is 0.75. Giving adenosine causes an
apparent rise in the ratio, such that during stable hyperaemia, the FFR
is 0.81. This likely represents adenosine mediated paradoxical
vasoconstriction of the microvasculature.
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The clinical implications of this paradox are unclear, particu-
larly because the occurrence rate in trials such the FAME studies
is unknown.6 7 Furthermore, many cardiologists would choose
not to give adenosine if the resting gradient is already below the
treatment threshold, while some cardiologists choose to use
lowest Pd/Pa ratio during adenosine infusion and thus may have
inadvertently missed or disregarded rising FFR values caused by
paradoxical effects of adenosine. Further assessment of this phe-
nomenon is required and it is the subject of upcoming studies.
After PCI, an iFR lower than FFR could represent the effect
of residual stenosis, but also of either residual hyperaemia as a
consequence of balloon inﬂation, which may artiﬁcially reduce
the iFR or the impact of microemboli preventing maximal
hyperaemia in response to adenosine. Intracoronary ﬂow vel-
ocity was not measured in this study, so it is not possible to
identify whether an increase in ﬂow (leading to a low iFR) or an
increase in resistance (leading to a higher than expected FFR)
was the likely cause of the differences between iFR and FFR.
Overall this cohort was small, and there was no difference in
the anatomical residual disease post-PCI to account for the six
cases where iFR was lower than FFR.
Relationship between anatomical stenosis severity
and physiological pressure indices
It is intuitive that the potential for either iFR or FFR to increase
following successful PCI was governed by the initial physio-
logical severity of the lesion. In this study we also found angio-
graphic signiﬁcance demonstrated a relationship. This is likely
to be due to our study design, where only patients with anatom-
ical stenosis with FFR≤0.80 were included. If physiological
assessment had been made pre–post-PCI in lesions deemed ana-
tomically signiﬁcant, with disregard for FFR, it is likely that the
relationship between stenosis QCA and improvement in
post-PCI physiology would have been signiﬁcantly worse.
Potential value and application of iFR to aid
coronary angioplasty
Despite the utility of FFR, physiological guidance pre-PCI is
performed in <10% of interventional cases.43 44 Less data for
post-PCI assessment is available but is likely to be a fraction of
pre-PCI assessment.45 Unmet needs include the cost of pressure
wires and reimbursement costs. Others are the time taken, the
availability of vasodilators and certainty of reaching maximum
hyperaemia.46 Even in the best hands, using intracoronary vaso-
dilators in a single vessel adds a median of 9 (IQR 7–13)
minutes onto a PCI procedure, while an infusion approach adds
11 (IQR 10–17) minutes.47 Multivessel assessment takes signiﬁ-
cantly longer.47 Simpliﬁcation of measurements could promote
physiological assessment in more vessels and in more patients.
Documenting incremental changes in physiological markers may
gain clinical importance as interventionists are increasingly
required to document the appropriateness of the procedure48
and the beneﬁt accrued.
Limitations
FFR has been afforded a signiﬁcant bias towards detecting a
greater change because only patients with FFR≤0.80 were
included. Therefore, while anatomically the lesions were moder-
ate, many were severe physiologically as seen in the pioneering
FFR trials.
FFR was measured using intracoronary adenosine in 20% of
patients. This reﬂects the routine clinical practice and the inter-
changeable way in which adenosine is administered. While
several studies have reported an overall excellent classiﬁcation
match between the techniques,49 it may have inadvertently
introduced additional variability into the FFR measurements,
which was not seen in the iFR arm which was always measured
at rest prior to administration of adenosine.
Central venous pressure (CVP) correction of the simpliﬁed
FFR calculation can improve the accuracy of the FFR measure-
ment, though it is rarely performed clinically and in trials.7 25
Future studies should consider formal assessment of the impact
of CVP measurement upon the relationship between physio-
logical indices, as well as deﬁning the conﬁdence boundaries of
change by performing repeated measures before and after PCI.
Future work should also measure coronary wedge pressure to
assess the impact of collateral vessels and the collateral ﬂow
index upon iFR measurement and how this affects iFR
post-PCI. The differing effects of collateral vessels between
resting and hyperaemic indices may explain important differ-
ences between iFR and FFR, and requires further assessment in
future studies.
In keeping with routine clinical practice, this study did not
measure coronary Doppler ﬂow velocity, and therefore did not
evaluate the speciﬁc impact of microcirculatory disease on ﬂow-
derived or pressure-ﬂow derived indices.
Conclusions
The incremental improvement in iFR following coronary angio-
plasty is similar to that of FFR and greater than Pd/Pa. Resting
indices such as iFR have the potential to be used as objective
measures of improvement in physiology following coronary
angioplasty.
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